Pulsed Field Ablation
FDA approves mapping, dual-energy catheter ablation system for persistent AF
Medtronic announced the FDA approval of its mapping and dual-energy catheter ablation system for the treatment of persistent atrial fibrillation and radiofrequency ablation of cavotricuspid isthmus-dependent atrial flutter.
FDA approves next-gen pulsed field ablation catheter for paroxysmal atrial fibrillation
Boston Scientific announced it received FDA approval for its navigation-enabled ablation catheter for the treatment of paroxysmal atrial fibrillation and 510(k) clearance for new imaging software for its pulsed field ablation system.
‘Under promise and over deliver’: Speaker highlights consensus on treating acne scars
ORLANDO — A speaker at the American Society for Dermatologic Surgery Annual Meeting highlighted a set of international consensus recommendations for the use of energy-based devices for acne scar treatment.
Pulsed field ablation linked to low complication rates in large real-world cohort
In the largest study to date of pulsed field ablation for patients with atrial fibrillation, the technology was associated with low rates of major complications, especially esophageal damage.
Pulsed field ablation system for AF demonstrates safety, efficacy in pivotal trial
A pulsed field ablation system was associated with low rates of safety events and high rates of efficacy for patients with paroxysmal atrial fibrillation at 12 months, according to the results of the admIRE pivotal trial.
Pulsed field ablation for AF may reduce arrhythmia burden better than thermal ablation
Pulsed field ablation lowered the odds of high residual atrial arrhythmia burden compared with thermal ablation for patients with atrial fibrillation at 1 year, according to a subanalysis of the ADVENT trial presented at Heart Rhythm 2024.
Large-tip, dual-energy ablation catheter shows promise as treatment for persistent AF
A platform with a mapping system and a large-tip catheter with dual pulsed field and radiofrequency energies was noninferior to a conventional radiofrequency ablation system for treatment of persistent atrial fibrillation, data show.
Pulsed field ablation catheter tied to favorable 30-day safety in real-world AF cohort
In a real-world registry of patients with atrial fibrillation treated with a pulsed field ablation catheter, the system was associated with favorable 30-day outcomes, researchers reported at Heart Rhythm 2024.
Top in cardiology: FDA OKs second pulsed field ablation system; BP drug reduces anxiety
The FDA approved a second pulsed field ablation system for the treatment of paroxysmal atrial fibrillation based on real-world data from the MANIFEST-17K registry and positive findings from the pivotal ADVENT clinical trial.
FDA approves second pulsed field ablation system to treat atrial fibrillation
The FDA approved a second pulsed field ablation system for the treatment of adults with drug-refractory, recurrent, symptomatic, paroxysmal atrial fibrillation.